Septra ds and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Septra ds (sulfamethoxazole; trimethoprim) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include arrhythmia supraventricular among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Septra ds and Combivent. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Septra ds?

Septra ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 2,349 Septra ds users. Check the latest studies of Septra ds.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.



On Jul, 19, 2026

22 people who take Septra ds and Combivent together, and have interactions are studied.

Septra ds and Combivent drug interactions.

What are the common drug interactions of Septra Ds and Combivent, by gender? *:

female:

  1. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Asthenia (weakness)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  7. B-cell lymphoma (blood cancer affecting b cells)
  8. Balance disorder
  9. Blood pressure increased
  10. Blood urea increased

male:

  1. Chest pain
  2. Fatigue (feeling of tiredness)
  3. Upper respiratory tract infection
  4. Weight decreased
  5. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  6. Anxiety
  7. Arteriovenous malformation
  8. Asthenia (weakness)
  9. Bone disorder
  10. Bone fistula

What are the common drug interactions of Septra Ds and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Fatigue (feeling of tiredness)
  2. Hyperglycaemia (high blood sugar)
  3. Weight increased
  4. Wheezing (a high-pitched whistling sound made while you breath)
  5. Abdominal pain
  6. Abdominal pain upper
  7. Accident
  8. Affect lability (emotional incontinence)
  9. Alcohol use
  10. Anxiety

40-49:

  1. Abdominal pain upper
  2. Arthralgia (joint pain)
  3. Blood ethanol increased
  4. Blood glucose increased
  5. Blood pressure increased
  6. Blood thyroid stimulating hormone increased
  7. Brain natriuretic peptide increased
  8. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  9. Cardiac failure congestive
  10. Cardiomyopathy alcoholic

50-59:

  1. Heart rate increased
  2. Hypotension (abnormally low blood pressure)
  3. Osteomyelitis (infection of bone)
  4. White blood cell count increased
  5. Hepatic steatosis (fatty liver disease)
  6. Intervertebral disc disorder (spinal disc disorder)
  7. Renal cyst (kidney cyst)
  8. Pharingeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Anaemia (lack of blood)

60+:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Depressed level of consciousness
  3. Dyspnoea (difficult or laboured respiration)
  4. Haemoglobin decreased
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hypotension (abnormally low blood pressure)
  7. Labile blood pressure (wildly fluctuating blood pressure)
  8. Post procedural complication
  9. Procedural hypotension
  10. Cardiac arrest

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 27.27%
  2. Multiple Myeloma (cancer of the plasma cells): 4 people, 18.18%
  3. Stress And Anxiety: 3 people, 13.64%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.64%
  5. Pneumonia: 2 people, 9.09%
  6. Pilonidal Cyst: 2 people, 9.09%
  7. Dyslipidaemia (abnormal amount of lipids): 2 people, 9.09%
  8. Diabetes: 2 people, 9.09%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 9.09%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Septra ds and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Septra ds and Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Septra ds:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Septra ds and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and albuterol sulfate; ipratropium bromide (the active ingredients of Septra ds and Combivent, respectively), and Septra ds and Combivent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: